EUVIMEDEUVIMED entdecken
Crossref

Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial

Ulla Lång, Johanna Metsälä, Hugh Ramsay, Fiona Boland, Katriina Heikkilä, Anna Pulakka, Anne Lawlor, Karen O'Connor, Juha Veijola, Eero Kajantie, Colm Healy, Ian Kelleher

American Journal of Psychiatry · 2026-02 · 183 (2) · 124-133

DOI: 10.1176/appi.ajp.20240958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Psychiatry, 2026-02. Verfasst von Ulla Lång und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh. Hauptthemen laut MEDLINE: Doxycycline, Schizophrenia, Anti-Bacterial Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: As many as half of individuals who develop psychosis had attended child and adolescent psychiatric services at some stage in childhood, highlighting substantial opportunities for prevention within these services if an effective preventive intervention were identified. The authors hypothesized that adolescent psychiatric patients exposed to doxycycline, an antibiotic with putative neuroprotective properties, would have a lower risk of developing schizophrenia. METHODS: This was an emulated target trial using nationwide Finnish health register data on all individuals born between 1987 and 1997 who attended adolescent psychiatric services between ages 13 and 18 and had used any antibiotics. Individuals were followed from first dispensed antibiotic prescription up to age 30. The main outcome was recorded schizophrenia diagnosis. The g-formula was used to estimate schizophrenia risk across doxycycline exposure levels (cumulative dose doxycycline use: no doxycycline use; low use,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclineSchizophreniaAnti-Bacterial AgentsHumansAdolescentMaleFemaleFinlandAdultRegistriesYoung AdultRisk Factors

Stichwörter der Autor:innen

Child/Adolescent PsychiatryDoxycyclineSchizophrenia Spectrum and Other Psychotic Disorders

Substanzen

DoxycyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh.
  • Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki.
  • Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
  • School of Population Health, RCSI University of Medicine and Health Sciences, Dublin.
  • Research Unit of Population Health, University of Oulu, Oulu, Finland.
  • 22Q11 Ireland, Dublin.

Zitieren

APA

Lång, U., Metsälä, J., Ramsay, H., Boland, F., Heikkilä, K., Pulakka, A., Lawlor, A., O'Connor, K., Veijola, J., Kajantie, E., Healy, C., & Kelleher, I. (2026). Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial. American Journal of Psychiatry, 183(2), 124-133. https://doi.org/10.1176/appi.ajp.20240958

Vancouver

Lång U, Metsälä J, Ramsay H, Boland F, Heikkilä K, Pulakka A, et al. Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial. American Journal of Psychiatry. 2026;183(2):124-133. doi:10.1176/appi.ajp.20240958

BibTeX
@article{Lng2026,
  author = {Lång, Ulla and Metsälä, Johanna and Ramsay, Hugh and Boland, Fiona and Heikkilä, Katriina and Pulakka, Anna and Lawlor, Anne and O'Connor, Karen and Veijola, Juha and Kajantie, Eero and Healy, Colm and Kelleher, Ian},
  title = {Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial},
  journal = {American Journal of Psychiatry},
  year = {2026},
  volume = {183},
  number = {2},
  pages = {124--133},
  doi = {10.1176/appi.ajp.20240958}
}
Kostenlos starten →